Ishita Drugs & Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve 1. To consider, approve ....

lsHITA DRUGS & INDUSTRIES LTD. Carp. Ofr* 401, 3rd Eye 11, Opp. Parimal Garden, C. G. Road. Ahmedabad-380006. Regd. Office & FaLctory : 179/I. \fasna-Iyava. Tal. Sanand. Disc Ahmedabad. E-mall : ishltadruzs®rmail.com I info@ishitadrufs.com I URL : www,ishitadrues.com Phone : +917226995613/14/15 I +9179 4002 3839 Date: 31.07.2026 The Department of Corporate`Services, The BSE Limited Floor No. 25, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai -400 001. Scrin Code: 524400 Dear Sir/Madam, Subject: Inl n 29 of the SEBI mstinE ObliEratieus a DisclosureRReouirementslReniL: for the quarter ended 30th Tune. 2026 Notice is hereby given that pursuant to Regulation 29 (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the meeting of the Board of Directors of the Company will be held on Saturday, 08th August, 2026 to transact the following business: 1. To consider, approve and take on record the Unaudited Financial Results of the Company for the quarter ended 30th June, 2026. 2. Any other matter with permission of the chair. Further in accordance with Code of Conduct for Prevention of Insider Trading Framed by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company by Designated Persons of the Company (`Code'), stands closed from Wednesday, 1st July, 2026 till 48 hours from the announcement of the Unaudited Financial Results for the qual-ter ended 30th )une, 2026. Kindly take the above on your records. Thanking You, For, ]shita Drugs and Industries Limited )agdish Agrawal Managing Director DIN: 01031687 •our 6ed¢ drigs in the seTvi¢e Of hunoridy uior(dwi4p CIN No. L24231GJ1992PLC017054 D & a D-U-N-S Number 65J)18ro359